-
公开(公告)号:US08367711B2
公开(公告)日:2013-02-05
申请号:US13483213
申请日:2012-05-30
申请人: Amjad Ali , Michael Man-Chu Lo , Christopher Franklin , Iyassu K. Sebhat , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-Chu Lo , Christopher Franklin , Iyassu K. Sebhat , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/41 , A61K31/405 , C07D209/00 , C07D257/04
CPC分类号: C07D403/10 , C07D235/20 , C07D257/04 , C07D409/06 , C07D493/04
摘要: A compound having the structure wherein R is, for example, Y is selected from the group consisting of 1) R5, 2) —C(R1R2) (C(R3R4))0-1Y1R5, and 3) —C(R1R2)—O—Y1R5; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is; Y1 is selected from the group consisting of C(O)—O— and P(O)(OR6)—O—; and R6 is hydrogen or CH3, or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.
摘要翻译: 具有其中R为例如Y的结构的化合物选自1)R5,2)-C(R1R2)(C(R3R4))0-1Y1R5和3)-C(R1R2) - O-Y1R5; R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是 Y1选自C(O)-O-和P(O)(OR 6)-O-; R6为氢或CH3,或其药学上可接受的盐,以及使用该化合物治疗高血压的方法。
-
公开(公告)号:US20120238608A1
公开(公告)日:2012-09-20
申请号:US13483213
申请日:2012-05-30
申请人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/4178 , A61P9/12 , C07D493/04
CPC分类号: C07D403/10 , C07D235/20 , C07D257/04 , C07D409/06 , C07D493/04
摘要: A compound having the structure wherein R is, for example, Y is selected from the group consisting of 1) R5, 2) —C(R1R2) (C(R3R4))0-1Y1R5, and 3) —C(R1R2)—O—Y1R5; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is; Y1 is selected from the group consisting of C(O)—O— and P(O)(OR6)—O—; and R6 is hydrogen or CH3, or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.
摘要翻译: 具有其中R为例如Y的结构的化合物选自1)R5,2)-C(R1R2)(C(R3R4))0-1Y1R5和3)-C(R1R2) - O-Y1R5; R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是 Y1选自C(O)-O-和P(O)(OR 6)-O-; R6为氢或CH3,或其药学上可接受的盐,以及使用该化合物治疗高血压的方法。
-
公开(公告)号:US20110065765A1
公开(公告)日:2011-03-17
申请号:US12992300
申请日:2009-05-06
申请人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/41 , C07D403/14 , A61P9/12
CPC分类号: C07D403/10 , C07D235/20 , C07D257/04 , C07D409/06 , C07D493/04
摘要: A compound having the structure R—Y wherein R is, for example, Y is selected from the group consisting of 1) R5, 2) —C(R1R2)(C(R3R4))0-1Y1R5, and 3) —C(R1R2)—O—Y1R5; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is Y1 is selected from the group consisting of —C(O)—O— and —P(O)(OR6)—O—; and R6 is hydrogen or CH3, or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.
摘要翻译: 具有结构R-Y的化合物,其中R为例如Y选自1)R 5,R 2,R 2,R 2,R 3,R 3,R 3, R1R2)-O-Y1R5; R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是Y1选自-C(O)-O-和-P(O)(OR6)-O-; R6为氢或CH3,或其药学上可接受的盐,以及使用该化合物治疗高血压的方法。
-
公开(公告)号:US08207208B2
公开(公告)日:2012-06-26
申请号:US12992300
申请日:2009-05-06
申请人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-chu Lo , Iyassu K. Sebhat , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/41 , A61K31/405 , C07D209/00 , C07D257/04
CPC分类号: C07D403/10 , C07D235/20 , C07D257/04 , C07D409/06 , C07D493/04
摘要: A compound having the structure R—Y wherein R is, for example, Y is selected from the group consisting of 1) R5, 2) —C(R1R2)(C(R3R4))0-1Y1R5, and 3) —C(R1R2)—O—Y1R5; R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is Y1 is selected from the group consisting of —C(O)—O— and —P(O)(OR6)—O—; and R6 is hydrogen or CH3, or a pharmaceutically acceptable salt thereof, and methods of using the compounds for treating hypertension.
摘要翻译: 具有结构R-Y的化合物,其中R为例如Y选自1)R 5,R 2,R 2,R 2,R 3,R 3,R 3, R1R2)-O-Y1R5; R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是Y1选自-C(O)-O-和-P(O)(OR6)-O-; R6为氢或CH3,或其药学上可接受的盐,以及使用该化合物治疗高血压的方法。
-
公开(公告)号:US08252825B2
公开(公告)日:2012-08-28
申请号:US12743402
申请日:2008-11-21
申请人: Amjad Ali , Michael Man-Chu Lo , Christopher Franklin , Nicoletta Almirante , Silvia Stefanini , Laura Storoni , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-Chu Lo , Christopher Franklin , Nicoletta Almirante , Silvia Stefanini , Laura Storoni , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/4184 , A61K31/4178 , C07D403/10 , A61P9/12
CPC分类号: C07D403/10
摘要: A compound having the structure wherein R is an angiotensin receptor antagonist active group, and Y is 1) —(CH2)3R5, 2) —C(O)(CH2)2R5, 3) —C(R1R2)OC(O)O(CH2)nR5, wherein n is 1 or 2, 4) —C(R1R2)OC(O)CH2CH2R5, 5) —C(R1R2)OC(O)OCH2CH2C(R3R4)R5, provided that when Y is —C(O)(CH2)2R5, then R is R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is —CH(ONO2)CH(ONO2)R6; R6 is selected from CH3, CH2CH3 and CH(CH3)2; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
摘要翻译: 具有结构的化合物,其中R是血管紧张素受体拮抗剂活性基团,Y是1) - (CH 2)3 R 5,2)-C(O)(CH 2)2 R 5,3)-C(R 1 R 2)OC(O)O (CH 2)n R 5,其中n为1或2,4)-C(R 1 R 2)OC(O)CH 2 CH 2 R 5,5)-C(R 1 R 2)OC(O)OCH 2 CH 2 C(R 3 R 4) O)(CH 2)2 R 5,则R 1是R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是-CH(ONO2)CH(ONO2)R6; R 6选自CH 3,CH 2 CH 3和CH(CH 3)2; 或其药学上可接受的盐或水合物,其可用于治疗高血压。
-
公开(公告)号:US20100311800A1
公开(公告)日:2010-12-09
申请号:US12867050
申请日:2009-02-19
申请人: Nicoletta Almirante , Alessia Nicotra , Silvia Stefanini , Stefano Biondi , Ennio Ongini , Amjad Ali , Michael Man-chu Lo
发明人: Nicoletta Almirante , Alessia Nicotra , Silvia Stefanini , Stefano Biondi , Ennio Ongini , Amjad Ali , Michael Man-chu Lo
IPC分类号: A61K31/41 , C07D257/04 , A61P9/12
CPC分类号: C07D257/04 , C07D403/10 , C07D409/06
摘要: The present invention relates to nitrooxyderivatives of angiotensin II receptor antagonists.
摘要翻译: 本发明涉及血管紧张素II受体拮抗剂的硝基氧基衍生物。
-
公开(公告)号:US20100273845A1
公开(公告)日:2010-10-28
申请号:US12743402
申请日:2008-11-21
申请人: Amjad Ali , Michael Man-Chu Lo , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Laura Storoni , Stefano Biondi , Ennio Ongini
发明人: Amjad Ali , Michael Man-Chu Lo , Chris Franklin , Nicoletta Almirante , Silvia Stefanini , Laura Storoni , Stefano Biondi , Ennio Ongini
IPC分类号: A61K31/4184 , C07D403/10 , A61P9/12 , A61K31/4178
CPC分类号: C07D403/10
摘要: A compound having the structure wherein R is an angiotensin receptor antagonist active group, and Y is 1) —(CH2)3R5, 2) —C(O)(CH2)2R5, 3) —C(R1R2)OC(O)O(CH2)nR5, wherein n is 1 or 2, 4) —C(R1R2)OC(O)CH2CH2R5, 5) —C(R1R2)OC(O)OCH2CH2C(R3R4)R5, provided that when Y is —C(O)(CH2)2R5, then R is R1, R2, R3 and R4 are independently selected from the group consisting of hydrogen and C1-4 alkyl; R5 is —CH(ONO2)CH(ONO2)R6; R6 is selected from CH3, CH2CH3 and CH(CH3)2; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
摘要翻译: 具有结构的化合物,其中R是血管紧张素受体拮抗剂活性基团,Y是1) - (CH 2)3 R 5,2)-C(O)(CH 2)2 R 5,3)-C(R 1 R 2)OC(O)O (CH 2)n R 5,其中n为1或2,4)-C(R 1 R 2)OC(O)CH 2 CH 2 R 5,5)-C(R 1 R 2)OC(O)OCH 2 CH 2 C(R 3 R 4) O)(CH 2)2 R 5,则R 1是R 1,R 2,R 3和R 4独立地选自氢和C 1-4烷基; R5是-CH(ONO2)CH(ONO2)R6; R 6选自CH 3,CH 2 CH 3和CH(CH 3)2; 或其药学上可接受的盐或水合物,其可用于治疗高血压。
-
公开(公告)号:US20110052674A1
公开(公告)日:2011-03-03
申请号:US12866688
申请日:2009-02-19
申请人: Nicoletta Almirante , Alessia Nicotra , Valentino Mandelli , Stefano Biondi , Silvia Stefanini , Iyassu K. Sebhat , Michael Man-Chu Lo
发明人: Nicoletta Almirante , Alessia Nicotra , Valentino Mandelli , Stefano Biondi , Silvia Stefanini , Iyassu K. Sebhat , Michael Man-Chu Lo
IPC分类号: A61K9/127 , C07D403/10 , A61K31/41 , C07D403/14 , C07D471/04 , A61K31/519 , C07D257/04 , A61K31/4184 , C07D409/06 , A61K31/4178 , A61K9/12 , A61K9/28 , A61K9/48 , A61P9/00 , A61P13/12 , A61P27/06 , A61P25/00
CPC分类号: C07D403/10 , C07D403/14 , C07D405/14
摘要: New angiotensin II receptor blocker nitroderivatives of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof: and their use for treating cardiovascular, renal and chronic liver diseases, inflammatory processes and metabolic syndromes.
摘要翻译: 通式(I)的新型血管紧张素II受体阻断剂硝基衍生物及其药学上可接受的盐或立体异构体及其用于治疗心血管,肾脏和慢性肝脏疾病,炎症过程和代谢综合征的用途。
-
公开(公告)号:US07880014B2
公开(公告)日:2011-02-01
申请号:US12000247
申请日:2007-12-11
申请人: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
发明人: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
IPC分类号: C07D257/00 , C07D403/00
CPC分类号: C07D403/10
摘要: A compound having the structure wherein R is an angiotensin receptor antagonist active group, Y is -Y1-Y2-Y3-Y4-Y5-; Y1 is C(R1R2); R1 is selected from the group consisting of hydrogen and C1-4 alkyl; R2 is selected from the group consisting of hydrogen, C1-4 alkyl, and —OC(O)C1-4 alkyl; Y2 is O or CH2; Y3 is C(O) or CH2; Y4 is O or CH2; Y5 is —(CH2)1-2—(X)0-1—(CH2)0-1— or is absent; X is —O— or —CR3R4—; and R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
摘要翻译: 具有结构的化合物,其中R是血管紧张素受体拮抗剂活性基团,Y是-Y1-Y2-Y3-Y4-Y5-; Y1是C(R1R2); R 1选自氢和C 1-4烷基; R 2选自氢,C 1-4烷基和-OC(O)C 1-4烷基; Y2是O或CH2; Y 3是C(O)或CH 2; Y4是O或CH2; Y 5是 - (CH 2)1-2 - (X)0-1 - (CH 2)0-1-或不存在; X是-O-或-CR 3 R 4 - ; 并且R 3和R 4独立地选自氢和C 1 -C 4烷基; 或其药学上可接受的盐或水合物,其可用于治疗高血压。
-
公开(公告)号:US20100152259A1
公开(公告)日:2010-06-17
申请号:US12516482
申请日:2007-12-11
申请人: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
发明人: Iyassu K. Sebhat , Michael Man-chu Lo , Ravi P. Nargund , Amjad Ali , Chris Franklin , Nicoletta Almirante , Laura Storoni , Silvia Stefanini
IPC分类号: C07D403/10 , A61K31/4184 , A61P9/12
CPC分类号: C07D403/10
摘要: A compound having the structure (Formula I), wherein R an angiotensin receptor antagonist active group, Y is Y1—Y2—Y3—Y4—Y5. Y1 is C(R1R2); R1 is selected from the group consisting of hydrogen and C1-4 alkyl; R2 is selected from the group consisting of hydrogen, C1-4 alkyl, and -0C(0)C1-4 alkyl; Y2 is O or CH2; Y3 is C(O) or CH2; Y4 is O or CH2; Y5 is —(CH2)1-2—(X)0-1—CH2)0-1— or is absent; X is —O— or —CR3R4—; and R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.
摘要翻译: 具有结构(式I)的化合物,其中R为血管紧张素受体拮抗剂活性基团,Y为Y1-Y2-Y3-Y4-Y5。 Y1是C(R1R2); R 1选自氢和C 1-4烷基; R 2选自氢,C 1-4烷基和-C(O)C 1-4烷基; Y2是O或CH2; Y 3是C(O)或CH 2; Y4是O或CH2; Y 5是 - (CH 2)1-2 - (X)0-1-CH 2)0-1-或不存在; X是-O-或-CR 3 R 4 - ; 并且R 3和R 4独立地选自氢和C 1 -C 4烷基; 或其药学上可接受的盐或水合物,其可用于治疗高血压。
-
-
-
-
-
-
-
-
-